Conditions

General

• Safety and side effects of cannabidiol, a Cannabis sativa constituent (PubMed)
• Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action (PubMed)
• Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (PubMed)
• Cannabidiol: An overview of some pharmacological aspects (PubMed)
• Cannabidiol: An overview of some chemical and pharmacological aspects. Part I: chemical aspects(PubMed)
• The endocannabinoid system as an emerging target of pharmacotherapy (PubMed)
• Therapeutic potential of cannabinoid-based drugs (PubMed)
• Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities (PubMed)
• Cannabis-based medicines–GW pharmaceuticals: High CBD, high THC, medicinal cannabis–GW pharmaceuticals, THC:CBD (PubMed)
• The therapeutic potential of cannabis and cannabinoids (PubMed)
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines (PubMed)
• Therapeutic potential of cannabinoid-based drugs (PubMed)
• Cannabinoids in clinical practice (PubMed)
• Cannabinoids (PubMed)
• Pharmacology of cannabinoids (PubMed)
• Combined cannabinoid therapy via an oromucosal spray (PubMed)
• Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb(PubMed)
• Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology (PubMed)
• Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system (PubMed)
• Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants(PubMed)
• A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (PubMed)
• Clinical Studies With Cannabis and Cannabinoids, 2005-2009 (O’Shaughnessy’s)

Go back to see more conditions...